tiprankstipranks
Edwards Lifesciences (EW)
NYSE:EW
US Market
EW
Edwards Lifesciences
RESEARCH TOOLSreports
Want to see EW full AI Analyst Report?

Edwards Lifesciences (EW) Stock Forecast & Price Target

1,942 Followers
See the Price Targets and Ratings of:

EW Analyst Ratings

Moderate Buy
22Ratings
Moderate Buy
16 Buy
6 Hold
0 Sell
Based on 22 analysts giving stock ratings to
Edwards
Lifesciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EW Stock 12 Month Forecast

Average Price Target

$96.47
▲(19.11% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is $96.47 with a high forecast of $110.00 and a low forecast of $86.00. The average price target represents a 19.11% change from the last price of $80.99.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"70":"$70","111":"$111","80.25":"$80.3","90.5":"$90.5","100.75":"$100.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":110,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$110.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":96.47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$96.47</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$86.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[70,80.25,90.5,100.75,111],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.26,83.47076923076924,85.68153846153847,87.8923076923077,90.10307692307693,92.31384615384616,94.52461538461539,96.73538461538462,98.94615384615385,101.15692307692308,103.36769230769231,105.57846153846154,107.78923076923077,{"y":110,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.26,82.43,83.60000000000001,84.77000000000001,85.94,87.11,88.28,89.45,90.62,91.79,92.96000000000001,94.13,95.3,{"y":96.47,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.26,81.6246153846154,81.98923076923077,82.35384615384616,82.71846153846154,83.08307692307693,83.44769230769231,83.8123076923077,84.17692307692307,84.54153846153847,84.90615384615384,85.27076923076923,85.63538461538462,{"y":86,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.87,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.18,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.33,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.31,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.27,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.25,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.65,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.18,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.26,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$110.00Average Price Target$96.47Lowest Price Target$86.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on EW
Josh Jennings
TD Cowen
TD Cowen
$97
Buy
19.77%
Upside
Reiterated
04/17/26
Edwards Lifesciences (EW) Gets a Buy from TD Cowen
Mizuho Securities Analyst forecast on EW
Anthony Petrone
Mizuho Securities
Mizuho Securities
$136→$95
Buy
17.30%
Upside
Assigned
04/13/26
Edwards Lifesciences price target lowered to $95 from $100 at MizuhoEdwards Lifesciences price target lowered to $95 from $100 at Mizuho
RBC Capital Analyst forecast on EW
Shagun Singh Chadha
RBC Capital
RBC Capital
$100
Buy
23.47%
Upside
Reiterated
04/13/26
RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)
Citi Analyst forecast on EW
Joanne Wuensch
Citi
Citi
$101
Buy
24.71%
Upside
Reiterated
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), Alcon (NYSE: ALC) and Elanco Animal Health (NYSE: ELAN)
Evercore ISI Analyst forecast on EW
Vijay Kumar
Evercore ISI
Evercore ISI
$94→$92
Buy
13.59%
Upside
Assigned
04/06/26
Edwards Lifesciences price target lowered to $92 from $94 at Evercore ISIEdwards Lifesciences price target lowered to $92 from $94 at Evercore ISI
Wolfe Research Analyst forecast on EW
Michael Polark
Wolfe Research
Wolfe Research
$92
Buy
13.59%
Upside
Upgraded
04/01/26
Edwards Lifesciences (EW) was upgraded to a Buy Rating at Wolfe Research
J.P. Morgan Analyst forecast on EW
Robbie Marcus
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
03/30/26
Edwards Lifesciences: TRISCEND II Data and EVOQUE Differentiation Underpin Buy Rating and Long-Term Growth Outlook
Jefferies Analyst forecast on EW
Matthew Taylor
Jefferies
Jefferies
$102
Buy
25.94%
Upside
Reiterated
03/16/26
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Plus Therapeutics (PSTV)
Barclays Analyst forecast on EW
Matt Miksic
Barclays
Barclays
$104
Buy
28.41%
Upside
Reiterated
03/11/26
Barclays Sticks to Its Buy Rating for Edwards Lifesciences (EW)
BTIG Analyst forecast on EW
Marie Thibault
BTIG
BTIG
$103
Buy
27.18%
Upside
Reiterated
02/18/26
BTIG Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
UBS Analyst forecast on EW
Danielle Antalffy
UBS
UBS
$94→$90
Hold
11.12%
Upside
Reiterated
02/12/26
Edwards Lifesciences price target lowered to $90 from $94 at UBSEdwards Lifesciences price target lowered to $90 from $94 at UBS
Morgan Stanley Analyst forecast on EW
Patrick Wood
Morgan Stanley
Morgan Stanley
$86
Hold
6.19%
Upside
Reiterated
02/12/26
Edwards Lifesciences (EW) Receives a Hold from Morgan Stanley
Piper Sandler Analyst forecast on EW
Adam Maeder
Piper Sandler
Piper Sandler
$98→$100
Buy
23.47%
Upside
Reiterated
02/11/26
Piper Sandler Sticks to Its Buy Rating for Edwards Lifesciences (EW)
Truist Financial Analyst forecast on EW
Richard Newitter
Truist Financial
Truist Financial
$92→$89
Hold
9.89%
Upside
Reiterated
02/11/26
Truist Financial Keeps Their Hold Rating on Edwards Lifesciences (EW)
Oppenheimer Analyst forecast on EW
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
02/11/26
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on EW
Josh Jennings
TD Cowen
TD Cowen
$97
Buy
19.77%
Upside
Reiterated
04/17/26
Edwards Lifesciences (EW) Gets a Buy from TD Cowen
Mizuho Securities Analyst forecast on EW
Anthony Petrone
Mizuho Securities
Mizuho Securities
$136→$95
Buy
17.30%
Upside
Assigned
04/13/26
Edwards Lifesciences price target lowered to $95 from $100 at MizuhoEdwards Lifesciences price target lowered to $95 from $100 at Mizuho
RBC Capital Analyst forecast on EW
Shagun Singh Chadha
RBC Capital
RBC Capital
$100
Buy
23.47%
Upside
Reiterated
04/13/26
RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)
Citi Analyst forecast on EW
Joanne Wuensch
Citi
Citi
$101
Buy
24.71%
Upside
Reiterated
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (NYSE: EW), Alcon (NYSE: ALC) and Elanco Animal Health (NYSE: ELAN)
Evercore ISI Analyst forecast on EW
Vijay Kumar
Evercore ISI
Evercore ISI
$94→$92
Buy
13.59%
Upside
Assigned
04/06/26
Edwards Lifesciences price target lowered to $92 from $94 at Evercore ISIEdwards Lifesciences price target lowered to $92 from $94 at Evercore ISI
Wolfe Research Analyst forecast on EW
Michael Polark
Wolfe Research
Wolfe Research
$92
Buy
13.59%
Upside
Upgraded
04/01/26
Edwards Lifesciences (EW) was upgraded to a Buy Rating at Wolfe Research
J.P. Morgan Analyst forecast on EW
Robbie Marcus
J.P. Morgan
J.P. Morgan
―
Buy
―
Reiterated
03/30/26
Edwards Lifesciences: TRISCEND II Data and EVOQUE Differentiation Underpin Buy Rating and Long-Term Growth Outlook
Jefferies Analyst forecast on EW
Matthew Taylor
Jefferies
Jefferies
$102
Buy
25.94%
Upside
Reiterated
03/16/26
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Plus Therapeutics (PSTV)
Barclays Analyst forecast on EW
Matt Miksic
Barclays
Barclays
$104
Buy
28.41%
Upside
Reiterated
03/11/26
Barclays Sticks to Its Buy Rating for Edwards Lifesciences (EW)
BTIG Analyst forecast on EW
Marie Thibault
BTIG
BTIG
$103
Buy
27.18%
Upside
Reiterated
02/18/26
BTIG Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
UBS Analyst forecast on EW
Danielle Antalffy
UBS
UBS
$94→$90
Hold
11.12%
Upside
Reiterated
02/12/26
Edwards Lifesciences price target lowered to $90 from $94 at UBSEdwards Lifesciences price target lowered to $90 from $94 at UBS
Morgan Stanley Analyst forecast on EW
Patrick Wood
Morgan Stanley
Morgan Stanley
$86
Hold
6.19%
Upside
Reiterated
02/12/26
Edwards Lifesciences (EW) Receives a Hold from Morgan Stanley
Piper Sandler Analyst forecast on EW
Adam Maeder
Piper Sandler
Piper Sandler
$98→$100
Buy
23.47%
Upside
Reiterated
02/11/26
Piper Sandler Sticks to Its Buy Rating for Edwards Lifesciences (EW)
Truist Financial Analyst forecast on EW
Richard Newitter
Truist Financial
Truist Financial
$92→$89
Hold
9.89%
Upside
Reiterated
02/11/26
Truist Financial Keeps Their Hold Rating on Edwards Lifesciences (EW)
Oppenheimer Analyst forecast on EW
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Reiterated
02/11/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Edwards Lifesciences

3 Months
xxx
Success Rate
17/25 ratings generated profit
68%
Average Return
+1.38%
reiterated a xxx
 rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 68.00% of your transactions generating a profit, with an average return of +1.38% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
17/25 ratings generated profit
68%
Average Return
+11.44%
upgraded a buy rating 6 months ago
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 68.00% of your transactions generating a profit, with an average return of +11.44% per trade.
2 Years
xxx
Success Rate
13/21 ratings generated profit
62%
Average Return
+3.71%
reiterated a xxx
 rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 61.90% of your transactions generating a profit, with an average return of +3.71% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EW Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
60
45
54
41
29
Hold
32
13
19
12
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
92
58
73
53
38
In the current month, EW has received 29 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. EW average Analyst price target in the past 3 months is 96.47.
Each month's total comprises the sum of three months' worth of ratings.

EW Financial Forecast

EW Earnings Forecast

Next quarter’s earnings estimate for EW is $0.73 with a range of $0.71 to $0.75. The previous quarter’s EPS was $0.58. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s earnings estimate for EW is $0.73 with a range of $0.71 to $0.75. The previous quarter’s EPS was $0.58. EW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Sales Forecast

Next quarter’s sales forecast for EW is $1.60B with a range of $1.56B to $1.63B. The previous quarter’s sales results were $1.57B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.
Next quarter’s sales forecast for EW is $1.60B with a range of $1.56B to $1.63B. The previous quarter’s sales results were $1.57B. EW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year EW has Performed in-line its overall industry.

EW Stock Forecast FAQ

What is EW’s average 12-month price target, according to analysts?
Based on analyst ratings, Edwards Lifesciences’s 12-month average price target is 96.47.
    What is EW’s upside potential, based on the analysts’ average price target?
    Edwards Lifesciences has 19.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EW a Buy, Sell or Hold?
          Edwards Lifesciences has a consensus rating of Moderate Buy which is based on 16 buy ratings, 6 hold ratings and 0 sell ratings.
            What is Edwards Lifesciences’s price target?
            The average price target for Edwards Lifesciences is 96.47. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $110.00 ,the lowest forecast is $86.00. The average price target represents 19.11% Increase from the current price of $80.99.
              What do analysts say about Edwards Lifesciences?
              Edwards Lifesciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of EW?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.